标题 |
Efficacy and safety of edaravone (MCI-186) for the treatment of amyotrophic lateral sclerosis (ALS): a 24-week extension
依达拉奉(MCI-186)治疗肌萎缩侧索硬化(ALS)的疗效和安全性:延长24周
|
网址 | |
DOI | |
求助人 | |
下载 |